UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial

Osteoarthritis and cartilage, 2016-11, Vol.24 (11), p.1858-1866

2016

Volltextzugriff (PDF)

The prevalence of musculoskeletal pain and therapy needs in adults with Osteogenesis Imperfecta (OI) a cross-sectional analysis

BMC musculoskeletal disorders, 2022-05, Vol.23 (1), p.485-485, Article 485

2022

Volltextzugriff (PDF)

Osteoporosis: strategies for prevention and management

Best practice & research. Clinical rheumatology, 2007-02, Vol.21 (1), p.109-122

Keen, Richard, BSc, PhD, MRCP

2007

Volltextzugriff (PDF)

Congenital hallux valgus occurs in Fibrodysplasia Ossificans Progressiva and BMPR1B-associated dysplasia: an important distinction

BMC medical genomics, 2024-06, Vol.17 (1), p.160-6

2024

Volltextzugriff (PDF)

Aneurysm of the anterior tibial artery as a complication of infectious endocarditis

Vascular, 2021-08, Vol.29 (4), p.606-609

2021

Volltextzugriff (PDF)

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva

BMC medical research methodology, 2023-11, Vol.23 (1), p.1-269, Article 269

2023

Volltextzugriff (PDF)

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

Rheumatic & musculoskeletal diseases open, 2020-07, Vol.6 (2), p.e001306

2020

Volltextzugriff (PDF)

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

Orphanet journal of rare diseases, 2023-09, Vol.18 (1), p.1-304, Article 304

2023

Volltextzugriff (PDF)

I118 How should we treat osteoporosis in patients with CKD?

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

Keen, Richard

2019

Volltextzugriff (PDF)

I019 CNO and SAPHO syndrome from the adult perspective

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

Keen, Richard

2019

Volltextzugriff (PDF)

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1199-1207

2019

Volltextzugriff (PDF)

Online education improves competence in identifying fibrodysplasia ossificans progressiva (FOP)

Bone Reports, 2021-04, Vol.14, p.100996, Article 100996

2021

Volltextzugriff (PDF)

Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP)

BMC musculoskeletal disorders, 2022-06, Vol.23 (1), p.519-519, Article 519

2022

Volltextzugriff (PDF)

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

Frontiers in endocrinology (Lausanne), 2021-11, Vol.12, p.732728-732728

2021

Volltextzugriff (PDF)

Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance

Orphanet journal of rare diseases, 2020-05, Vol.15 (1), p.117-117, Article 117

2020

Volltextzugriff (PDF)

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

Rheumatic & musculoskeletal diseases open, 2021-09, Vol.7 (3), p.e001714

2021

Volltextzugriff (PDF)

PC132. Using Cephalic or Axillary Vein to Femoral Vein Bypass as Surgical Treatment of Symptomatic Venous Hypertension in Dialysis Patients With Central Venous Occlusion

Journal of vascular surgery, 2016-06, Vol.63 (6), p.193S-193S

2016

Volltextzugriff (PDF)

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Therapeutic advances in chronic disease, 2024-01, Vol.15, p.20406223241247643-20406223241247643

2024

Volltextzugriff (PDF)

Staged brachioradial artery to brachioradial vein arteriovenous fistula creation for hemodialysis access in three patients with a high origin of the radial artery

Journal of vascular surgery cases and innovative techniques, 2021-06, Vol.7 (2), p.271-274

2021

Volltextzugriff (PDF)

Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva

Orphanet journal of rare diseases, 2020-07, Vol.15 (1), p.1-193, Article 193

2020

Volltextzugriff (PDF)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Rheumatic & musculoskeletal diseases open, 2023-02, Vol.9 (1), p.e002676

2023

Volltextzugriff (PDF)

International physician survey on management of FOP: a modified Delphi study

Orphanet journal of rare diseases, 2017-06, Vol.12 (1), p.110-110, Article 110

2017

Volltextzugriff (PDF)

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Therapeutic advances in chronic disease, 2022, Vol.13, p.20406223221117471-20406223221117471

2022

Volltextzugriff (PDF)

Four patients with a clinically significant radial artery anomaly

Journal of vascular surgery cases and innovative techniques, 2019-06, Vol.5 (2), p.104-106

2019

Volltextzugriff (PDF)

Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes

Orphanet journal of rare diseases, 2019-05, Vol.14 (1), p.113-113, Article 113

2019

Volltextzugriff (PDF)

1 – 25 von 377

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(296)
Mit Volltextzugriff
(273)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(376)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial

The prevalence of musculoskeletal pain and therapy needs in adults with Osteogenesis Imperfecta (OI) a cross-sectional analysis

Osteoporosis: strategies for prevention and management

Congenital hallux valgus occurs in Fibrodysplasia Ossificans Progressiva and BMPR1B-associated dysplasia: an important distinction

Aneurysm of the anterior tibial artery as a complication of infectious endocarditis

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva

Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

I118 How should we treat osteoporosis in patients with CKD?

I019 CNO and SAPHO syndrome from the adult perspective

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)

Online education improves competence in identifying fibrodysplasia ossificans progressiva (FOP)

Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP)

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

PC132. Using Cephalic or Axillary Vein to Femoral Vein Bypass as Surgical Treatment of Symptomatic Venous Hypertension in Dialysis Patients With Central Venous Occlusion

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Staged brachioradial artery to brachioradial vein arteriovenous fistula creation for hemodialysis access in three patients with a high origin of the radial artery

Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

International physician survey on management of FOP: a modified Delphi study

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Four patients with a clinically significant radial artery anomaly

Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes

Aktive Filter

Suchergebnisse filtern